TH9 cells in anti-tumor immunity - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Seminars in Immunopathology Année : 2016

TH9 cells in anti-tumor immunity

Résumé

IL-9 was initially identified as a T cell growth factor with a potential oncogenic activity. Accordingly, IL-9 drives tumor growth in most hematological cancers. However, the links between IL-9 and cancer progression have been recently revisited following the discovery of TH9 cells. TH9 cells, which have been characterized in 2008 as a proinflammatory CD4 T cell subset that promotes protection against parasites and drives tissue inflammation in colitis, actually harbor potent IL-9-dependent anti-cancer properties in solid tumors and especially melanoma. While the molecular mechanisms underlying these observations are still being investigated, TH9 cells were demonstrated to activate both innate and adaptive immune responses, thereby favoring anti-cancer immunity and tumor elimination. Human TH9 cells have also been identified in cancer tissues, but their functions remain elusive. The present review aims to discuss the anti-cancer potential of TH9 cells and their possible clinical relevance for cancer immunotherapy.

Domaines

Immunologie
Fichier principal
Vignette du fichier
Semin. Immunopathol. 10.1007s00281-016-0599-4.pdf (742.15 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

inserm-01416031 , version 1 (13-12-2016)

Identifiants

Citer

Thaiz Rivera Vargas, Etienne Humblin, Frédérique Végran, Francois Ghiringhelli, Lionel Apetoh. TH9 cells in anti-tumor immunity. Seminars in Immunopathology, 2016, [Epub ahead of print]. ⟨10.1007/s00281-016-0599-4⟩. ⟨inserm-01416031⟩
93 Consultations
346 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More